EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Radiosurgery effects and adverse effects in symptomatic eloquent brain-located Cavernomas

Tanju Berber, Suat Erol Celik, Ferdi Aksaray, Adnan Yoney, Kemal Harmanci, Makbule Tambas, Binnur Dönmez Yılmaz, Cakir Numanoglu, Ahmet Yolcu, Hilal İrem Açan, Selvi Tabak Dinçer, Berna Akkuş Yıldırım

Journal of Radiation Research · 2023

DOI: 10.1093/jrr/rrac056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Radiation Research, 2023. Verfasst von Tanju Berber und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology and Radiosurgery, Okmeydani Training And Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Radiosurgery, Hemangioma, Cavernous, Central Nervous System, Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, the dose schedule efficacy, safety and late adverse effects of stereotactic radiosurgery (SRS) were evaluated for patients with symptomatic cavernomas who were not eligible for surgery and treated with SRS. Between January 2013 and December 2018, 53 patients with cavernomas were treated using SRS with the CyberKnife® system. Patients’ diseases were deeply located or were in subcortical functional brain regions. In addition to bleeding, 23 (43.4%) patients had epilepsy, 12 (22.6%) had neurologic symptoms and 16 patients (30.2%) had severe headaches. The median volume was 741 (range, 421–1351) mm3, and the median dose was 15 (range, 14–16) Gy in one fraction. After treatment, six (50%) of 12 patients with neurologic deficits still had deficits. Rebleeding after treatment developed in only two (3.8%) patients. The drug was completely stopped in 14 (60.9%) out of 23 patients who received epilepsy treatment, and the dose of levetiracetam decreased from 2000 mg to 1000 mg in four (17.3%) of nine patients. Radiologically, complete response (CR) was observed in 13 (24.5%) patients, and partial responses (PR) were observed in 32 (60.2%) patients. Clinical response of CR was observed in 30 (56.6%) patients, PR was observed in 16 (30.2%), stable disease (SD) was observed in three (5.7%) and four (7.5%) patients progressed. In conclusion, SRS applied in the appropriate dose schedule may be an effective and reliable method in terms of symptom control and prevention of rebleeding, especially in patients with inoperable cavernomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryHemangioma, Cavernous, Central Nervous SystemEpilepsyHumansLevetiracetamBrainTreatment OutcomeRetrospective StudiesFollow-Up Studies

Stichwörter der Autor:innen

cavernomacerebral cavernous malformations (CCMs)epilepsyhemangiomaseizuresstereotactic radiosurgery (SRS)

Substanzen

Levetiracetam

Autor:innen und Institutionen

  • Department of Radiation Oncology and Radiosurgery, Okmeydani Training And Research Hospital, Istanbul, Turkey.
  • Department of Neurosurgery, Okmeydani Training And Research Hospital, Istanbul, Turkey.
  • Department of Internal Medicine, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.
  • Department of Radiology, Okmeydani Training And Research Hospital, Istanbul, Turkey.
  • Department of Radiation Oncology, Namık Kemal University Medical Faculty of Medicine, Tekirdag, Turkey.

Zitieren

APA

Berber, T., Celik, S. E., Aksaray, F., Yoney, A., Harmanci, K., Tambas, M., Yılmaz, B. D., Numanoglu, C., Yolcu, A., Açan, H. İ., Dinçer, S. T., & Yıldırım, B. A. (2023). Radiosurgery effects and adverse effects in symptomatic eloquent brain-located Cavernomas. Journal of Radiation Research. https://doi.org/10.1093/jrr/rrac056

Vancouver

Berber T, Celik SE, Aksaray F, Yoney A, Harmanci K, Tambas M, et al. Radiosurgery effects and adverse effects in symptomatic eloquent brain-located Cavernomas. Journal of Radiation Research. 2023. doi:10.1093/jrr/rrac056

BibTeX
@article{Berber2023,
  author = {Berber, Tanju and Celik, Suat Erol and Aksaray, Ferdi and Yoney, Adnan and Harmanci, Kemal and Tambas, Makbule and Yılmaz, Binnur Dönmez and Numanoglu, Cakir and Yolcu, Ahmet and Açan, Hilal İrem and Dinçer, Selvi Tabak and Yıldırım, Berna Akkuş},
  title = {Radiosurgery effects and adverse effects in symptomatic eloquent brain-located Cavernomas},
  journal = {Journal of Radiation Research},
  year = {2023},
  doi = {10.1093/jrr/rrac056}
}
Kostenlos starten →